Groove Botanicals Inc (GRVE)

Healthcare | Drug Manufacturers Specialty Generic
Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

$0.0

Operating Margin

N/A

Free Cash Flow

-$107K

Debt / Assets

24,654.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Groove Botanicals Inc (GRVE).
Income Statement (Quarterly) 2025-09-30 2025-06-30 2024-12-31 2024-09-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 16,518 38,170 33,031 18,332
Operating Expenses 32,383 38,170 33,031 29,833
Operating Income 0 -38,170 -33,031 -29,833
Interest Expense 0 0 0 0
Income Before Tax 0 -38,170 -33,031 -29,833
Income Tax Expense 0 0 0 0
Net Income 0 -38,170 -33,031 -29,833
Per Share
EPS 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 0.00